Filing Details
- Accession Number:
- 0001209191-23-030192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-17 16:29:35
- Reporting Period:
- 2023-05-15
- Accepted Time:
- 2023-05-17 16:29:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1903865 | Samina Khan | 5320 Legacy Drive Plano TX 75024 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-05-15 | 288 | $85.32 | 39,843 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2023-05-16 | 352 | $81.37 | 39,491 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.